Vinkers, Christiaan H. http://orcid.org/0000-0003-3698-0744
Kupka, Ralph W. http://orcid.org/0000-0002-1662-7436
Penninx, Brenda W.
Ruhé, Henricus G. http://orcid.org/0000-0001-6072-0358
van Gaalen, Jakob M.
van Haaren, Paul C. F.
Schellekens, Arnt F. A.
Jauhar, Sameer http://orcid.org/0000-0002-3878-3659
Ramos-Quiroga, Josep A. http://orcid.org/0000-0003-1622-0350
Vieta, Eduard http://orcid.org/0000-0002-0548-0053
Tiihonen, Jari
Veldman, Stijn E.
Veling, Wim
Vis, Roeland
de Wit, Laura E.
Luykx, Jurjen J. http://orcid.org/0000-0002-6439-2774
Article History
Received: 25 August 2023
Revised: 22 December 2023
Accepted: 22 January 2024
First Online: 19 March 2024
Competing interests
: CV received research funding from ZonMW, Hersenstichting. HR received research funding from ZonMW, Hersenstichting, an unrestricted educational grant from Janssen and speaking fees from Janssen, Prelum, Benecke and Lundbeck. CV and HR are PIs of the TEMPO RCT examining different discontinuation strategies. SJ has received honoraria for educational talks given for Lundbeck, Boehringer-Ingelheim, Janssen and Sunovion. He has consulted for LLA Pharmaceuticals on an antipsychotic and has sat as panel member for a Wellcome Trust funding panel and expert member for a NICE panel on tardive dyskinesia. He is a Council Member for the British Association for Psychopharmacology (unpaid). JT has participated in research projects funded by grants from Janssen-Cilag and Eli Lilly to his employing institution. He has been a consultant to HLS Therapeutics, Janssen, Orion and WebMed Global and received lecture fees from Janssen and Otsuka. JR was on the speakers’ bureau and/or acted as consultant for Biogen, Janssen-Cilag, Novartis, Shire, Takeda, Bial, Shionogi, Sincrolab, Novartis, BMS, Medice, Rubió, Uriach, Technofarma and Raffo in the last 3 years. He also received travel awards (air tickets + hotel) for taking part in psychiatric meetings from Janssen-Cilag, Rubió, Shire, Takeda, Shionogi, Bial and Medice. The Department of Psychiatry chaired by him received unrestricted educational and research support from the following companies in the last 3 years: Janssen-Cilag, Shire, Oryzon, Roche, Psious, and Rubió. EV has received grants and served as consultant, advisor or CME speaker for the following entities (unrelated to the present work): AB-Biotics, Abbott, Abbvie, Aimentia, Angelini, Biogen, Biohaven, Boehringer-Ingelheim, Casen-Recordati, Celon, Compass, Dainippon Sumitomo Pharma, Ethypharm, Ferrer, Gedeon Richter, GH Research, Glaxo Smith-Kline, Idorsia, Janssen, Lundbeck, Novartis, Organon, Otsuka, Rovi, Sage, Sanofi-Aventis, Sunovion, Takeda, and Viatris. RV, LW, WV, AS, SV, JL, BP, JG, RK, and PH have no conflict of interests to declare.